European Monitoring Centre for Drugs and Drug Addiction. (2012) The Reitox network: frequently asked questions. Luxembourg: European Monitoring Centre for Drugs and Drug Addiction.
Preview | Title | Contact |
---|---|---|
PDF (The Reitox network)
- Published Version
865kB |
Table of contents
1.What is Reitox?
2.Who are members of the Reitox network?
3.What is the Reitox network’s main mission?
4.Is there a difference between a national focal point and a national drugs observatory?
5.What are the functions of Reitox national focal points at European level?
6.What are the functions of Reitox national focal points at national level?
7.How is Reitox managed?
8.How should a national focal point be structured?
9.What types of information should Reitox members provide to the EMCDDA and when?
10.How many staff members should work in a national focal point and what qualifications do they need?
11.How are Reitox national focal points financed?
12.What is the ‘Reitox Academy’?
13.Who can benefit from Reitox national focal points’ expertise at national level and how?
14.What is the added value in joining the Reitox network for non‐EU countries?
15.How can my country join the Reitox network?
16.Where canI find the contact details for Reitox members?
Repository Staff Only: item control page